Medications for Coronary Artery Disease

6 results
  • brilinta - ticagrelor tablet

    (Ticagrelor)
    Astrazeneca Pharmaceuticals Lp
    Brilinta reduces the risk of cardiovascular death, heart attack, and stroke in patients with acute coronary syndrome or prior heart attack. It also lowers the risk of first heart attack or stroke in high-risk coronary artery disease patients, and reduces stroke risk after mild ischemic stroke or high-risk TIA.
  • caduet - amlodipine besylate and atorvastatin calcium tablet, film coated

    (Amlodipine Besylate And Atorvastatin Calcium)
    Pfizer Laboratories Div Pfizer Inc
    Caduet combines amlodipine and atorvastatin. Amlodipine treats hypertension, chronic stable angina, vasospastic angina, and reduces cardiovascular risk in documented CAD. Atorvastatin reduces cardiovascular events in high-risk adults and lowers LDL-C in hyperlipidemia, familial hypercholesterolemia, dysbetalipoproteinemia, and hypertriglyceridemia.
  • katerzia - amlodipine suspension

    (Amlodipine)
    Azurity Pharmaceuticals, Inc.
    Katerzia is indicated for hypertension in adults and children 6+, and coronary artery disease including chronic stable angina, vasospastic (Prinzmetal's) angina, and angiographically documented CAD to reduce hospitalization for angina and coronary revascularization risk.
  • norvasc - amlodipine besylate tablet

    (Amlodipine Besylate)
    Viatris Specialty Llc
    NORVASC (amlodipine) is a calcium channel blocker indicated for hypertension, chronic stable angina, vasospastic (Prinzmetal's) angina, and angiographically documented coronary artery disease. It lowers blood pressure to reduce stroke and heart attack risk and reduces hospitalization for angina and need for coronary revascularization.